However, the incidence of driver mutations in squamous cell lung cancers is extremely low, [28] therefore EGFR/ALK/ROS1 mutations should have no impact on the findings reported for the stratified analysis on squamous cell lung cancer. This evidence concerns the gene ROS1 and squamous cell lung carcinoma.